Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the bra...
Enregistré dans:
Auteurs principaux: | Rúben G. R. Pinheiro, Ana Joyce Coutinho, Marina Pinheiro, Ana Rute Neves |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f8f503332d9e40ada4177774d6bea6d7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
par: Carely Hernandez, et autres
Publié: (2022) -
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
par: Claudia Riccardi, et autres
Publié: (2021) -
Topical Insights Into the Post-Approval Controversies of Aducanumab
par: Dhiraj Kumar, et autres
Publié: (2021) -
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
par: Peilin Sun, et autres
Publié: (2021) -
Drug delivery
Publié: (1993)